3
2
1

Hainan Lecheng Medical and Drug Administration went to Yinfeng Biological Group for investigation

Release time:

2023-05-31

On May 31, in order to implement the "Hainan Provincial Xi Implementation Plan for the Theme Education of Socialism with Chinese Characteristics in the New Era of Xi Jinping" and the "Implementation Plan for Daxing Research among Party Organizations and Party Members and Cadres at All Levels in the Province", effectively solve the urgency and anxiety of the enterprise development process, and further promote the smart medical work in the Lecheng Pilot Zone, the Lecheng Medical and Drug Administration went to the Shandong Medical Association and Yinfeng Biological Group to carry out inspection and research work.

乐城医疗药品监管局局长范斌一行到山东医学会和银丰生物集团总部调研,座谈交流。

11

Zhang Lin, vice president of Shandong Medical Association, Rao Lin, deputy secretary general, Zhang Weizhong, deputy secretary general and director of the office, and Wang Baoqing, chairman of Yinfeng Biological Group, accompanied the discussion and exchange, at which Vice President Zhang Lin introduced the development of Shandong Medical Association and the recent work in clinical research, new technology introduction and international exchanges, and raised questions to the Lecheng Medical and Drug Administration on how to land the new hospital project in the Lecheng Pilot Zone, qualification declaration and handling, department construction acceptance, licensed drug and equipment use, medical technology and nursing training and other related issues.

Fan Bin, director of the Lecheng Medical and Drug Administration, introduced the latest policy of the Lecheng Pilot Zone, the new development idea of "sharing, specialty, and alliance" and the regulatory concept of "one center, two bottom lines, and three initiatives", and said that the survey was vigorously promoted by the Shandong Provincial Medical Association to introduce high-quality medical resources in Shandong Province into the Lecheng Pilot Zone, further enrich the medical resources of the Lecheng Pilot Zone, and bring benign development to talent training. Subsequently, Zeng Guangrong, a second-level researcher of Lecheng Medical and Drug Administration, answered the biggest difficulties faced by the development of the enterprise at this stage and other related questions, turning "passive approval" into "active service" to empower the development of the enterprise.

Through this exchange, we will accelerate the revitalization of Shandong's medical resources, introduce Shandong's high-quality medical resources into the Hainan Boao Lecheng Pilot Zone, and promote Shandong medical treatment to the world with the help of the policies of the Lecheng Pilot Zone, and jointly promote the treatment of refractory diseases in the two places.

11

This research and exchange gave clear guidance and put forward relevant suggestions for the work of the later hospital project, pointed out the direction for the next step of discipline construction and specialty landing, and believed that through the cooperation of all parties, the high-quality development process of medical industry in Shandong and Hainan will be further accelerated.

11

Subsequently, Wang Baoqing, chairman of Yinfeng Biological Group, accompanied the research group to visit the "Infinite Life Plan" science museum and the "Life Extension Plan" exhibition hall successively, and learned in detail about the storage and application prospects of cells in 5G scenarios, the application of cryogenic medicine, the first case of human cryopreservation in Asia, and the infinite possibilities of cryomedicine in organ transplantation and clinical application.

11

During this exchange and inspection, the research group successively learned about the industrial layout, cutting-edge technology, R&D and innovation, and achievement transformation of Yinfeng Biological Group in the field of biomedicine, and highly recognized and praised the achievements of Yinfeng Biological Group.

11

Yinfeng Biological Group is a high-tech enterprise specializing in technology research and development, medical transformation and clinical research in the biomedical field such as human cells, tissues and organ storage, gene sequencing technology, cell application technology, cryogenic medical technology and health management services. In the past 19 years, Yinfeng Biotech has taken the lead in opening up the health management service industry chain covering the whole life cycle of human beings in the country, with the development vision of "becoming a leading domestic and international first-class health management service provider for the whole life cycle of human beings", and contributing to the service of "Healthy China".

Latest developments

The theme publicity activity of "Central Media Look at Jinan - Entering Jinan's Private Economy" was held in Yinfeng Biotechnology Park

On August 23, the Jinan Private Economic Development Bureau and China Economic Weekly jointly launched the theme publicity activity of "Central Media Look at Jinan - Entering Jinan's Private Economy" in Yinfeng Biotechnology Park.

Yinfeng Cryogenic and Anhui Medical University "Ministry of Education Engineering Research Center" project was accepted and awarded by the Ministry of Education

Led by Anhui Medical University and participated by Yinfeng Cryogenic Medical Technology Co., Ltd., the "Engineering Research Center for Life Resources Conservation and Artificial Organs of the Ministry of Education" was officially accepted and awarded by the Ministry of Education. As one of the four major platforms for the transformation of the center's project, Yinfeng Cryogenic Co., Ltd. is responsible for the "development, promotion and application of cryogenic preservation technology of biological matrix materials".

The inaugural meeting of the International Alliance for Life Extension Research was successfully concluded

On March 28, 2023, the kick-off meeting of the International Alliance for Life Extension Research was held in Jinan, Shandong. The "International Alliance for Life Extension Research" was initiated by Shandong Yinfeng Life Science Research Institute, and jointly established by 13 international scientific research institutions engaged in the field of cryogenic biomedicine from North America, Europe, Oceania, etc., and appeared at the conference through online and offline forms.